This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) creatinine equation to estimate GFR (eGFR)

Authoring team

Chronic kidney disease is monitored by glomerular filtration rate (GFR)

  • measured GFR is not widely used whereas estimates of GFR based on levels of serum creatinine are commonly used but can be inaccurate
  • cross sectional studies suggest that inclusion of cystatin C with creatinine in combined GFR estimating equations can improve the accuracy of assessing GFR

The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) developed equations to calculate eGFR based on serum creatinine; and another equation based on serum creatinine plus serum cystatin C

  • in patients with near-normal kidney function, the Modification of Diet in Renal Disease (MDRD) equations underestimate GFR
    • the CKD-EPI2009Scr equation partly overcomes the major limitation of the MDRD equation
  • the CKD-EPI working group developed two CKD-EPI equations (2):
    • one using cystatin C concentration (CKD-EPI2012cys) and the other using both cystatin C and serum creatinine concentrations (CKD-EPI2012Scr-cys)
    • equations were validated across the range of GFR and in relevant subgroups
  • there has been data that the CKD-EPI2012Scr-cys is superior to calculations based on serum creatinine alone (3,4,5)
    • a study in Chines population ((n = 788; median age, 54 [range, 19-94] years)) concluded (5) '..CKD-EPI2012Scr-cys appeared less biased and more accurate in overall participants. Neither of the new CKD-EPI equations achieved ideal accuracy in senior participants with moderately-severely injured GFR...'
  • a review states that overall, the CKD-EPICR-CYS equation had better precision and accuracy than that based on creatinine alone or CysC alone (6)
  • a study by Scandrett K et al showed (7)
    • GFR estimating equations based on both cystatin C and creatinine showed better agreement with changes in measured GFR over three years than equations based on one biomarker
    • all GFR estimating equations underestimated the temporal reduction in GFR

Reference:

  1. Levey AS, Stevens LA, Schmid CH, Zhang YP, Castro AF, et al.A New Equation to Estimate Glomerular Filtration Rate. Ann Intern Med 2009; 150: 604-612
  2. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012. Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int 2012;Suppl 3: 1-150.
  3. Mindikoglu AL, Dowling TC, Weir MR, Seliger SL, Christenson RH, et al.Performance of Chronic Kidney Disease Epidemiology Collaboration Creatinine-Cystatin C Equation for Estimating Kidney Function in Cirrhosis. Hepatology: 2013
  4. Obiols J, Bargnoux A-S, Kuster N, Fesler P, Pieroni L, et al. Validation of a new standardized cystatin C turbidimetric assay: Evaluation of the three novel CKD-EPI equations in hypertensive patients. Clin Biochem: 2013
  5. Ying Z et al. Comparisons between the 2012 New CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) Equations and Other Four Approved Equations.PLoS One. 2014; 9(1): e84688.
  6. Koppe L, Klich A, Dubourg L, Ecochard R, Hadj-Aissa A. Performance of creatinine-based equations compared in older patients. Journal of Nephrology. 2013;26:716-723
  7. Scandrett K et al. Accuracy of glomerular filtration rate estimation based on creatinine and cystatin C for monitoring moderate chronic kidney disease in adults: prospective, longitudinal cohort study. BMJ 2026; 392 :e085005

Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2026 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.